Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Semin Oncol Nurs. 2012 May;28(2):129–138. doi: 10.1016/j.soncn.2012.03.008

Table 1.

Candidate Genes As Potential Biomarkers for Common Symptoms in Oncology Patients*

Candidate Gene Categories Fatigue Pain Depression Sleep Disturbance
Inflammatory pathways Pro- and anti-inflammatory cytokine genes (e.g., IL1β, IL2, IL4, IL6, IL8, TNF)-α, interferon gamma) Pro- and anti-inflammatory cytokine genes (e.g., IL1β, IL2, IL4, IL6, IL8, TNF)-α, interferon gamma) Pro- and anti-inflammatory cytokine genes (e.g., IL1β, IL2, IL4, IL6, IL8, TNF)-α, interferon gamma) Pro- and anti-inflammatory cytokine genes (e.g., IL1β, IL2, IL4, IL6, IL8, TNF)-α, interferon gamma)
Neuroendocrine pathways – can include genes associated with the following mechanistic pathways: hypothalamic-pituitary-adrenal (HPA) axis, five hydroxtryptamine (5HT) neurotransmitter dysregulation, circadian rhythm disruption, alterations in adenosine triphosphate (ATP) metabolism, vagal afferent activation, and glucocorticoid signaling Genes associated with variations in serotonin, dopamine, and norepinephrine
Clock genes and genes associated with circadian rhythm
COMT
5-HTT
OPMR1
5HTT
Clock genes and genes associated with circadian rhythm
Genes associated with variations in serotonin, norepinephrine, and brain derived neurotrophic factor
Clock genes and genes associated with circadian rhythm
Genes associated with variations in serotonin, norepinephrine, and dopamine